Akorn Inc (AKRX) 38.21 $AKRX
SmarTrend Watching for Potential Pullback in Shares of Akorn After 1.41% Gain
Comtex SmarTrend(R) - 41 mins ago
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.90 to a high of $38.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $37.85 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 38.21 (+0.53)
Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 56 mins ago
Synageva BioPharma Corp. (GEVA) announced the presentation of new data from a phase III study on sebelipase alfa for LAL deficiency.
GEVA: 75.26 (-1.84), AKRX: 38.21 (+0.53), ADHD: 3.66 (+0.06), CELG: 104.05 (-3.38)
Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 88.11 (+1.15), KBIO: 2.10 (+0.04), AKRX: 38.21 (+0.53), MYL: 54.05 (-0.68)
Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Fri Nov 14, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $37.68 on volume of 3.0 million shares, above average daily volume of 1.7 million. Akorn (NASDAQ:AKRX) has potential upside of 9.0% based on a current price of $37.68 and analysts' consensus price target of $41.08. Akorn shares should encounter resistance at the 50-day moving average (MA) of $38.00 and support at its 200-day MA of $30.77.
AKRX: 38.21 (+0.53)
Stocks Rally Back After Midday Sell-Off
at Investor's Business Daily - Thu Nov 13, 12:17PM CST
Stocks were trying to recover after a midday sell-off lopped off most of the morning gains. The Nasdaq rose 0.3%, the S&P 500 was flat and the Dow Jones industrial average was up 0.2%. Volume was running at a higher pace than at the same time...
DDS: 111.79 (-0.97), AKRX: 38.21 (+0.53), WMT: 82.96 (+0.02), THRM: 40.43 (+0.30)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 85.71 (+0.76), AKRX: 38.21 (+0.53), WPC: 66.05 (-0.60), FLWS: 8.98 (-0.03), MMSI: 14.96 (-0.08)
Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 47.84 (+0.10), AKRX: 38.21 (+0.53), AEO: 13.50 (-0.08), M: 62.05 (+0.48), FANG: 67.79 (+3.03)
Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.21 (+0.53)
Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 38.21 (+0.53)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), AFSI: 52.48 (+0.32), EXPE: 87.93 (+1.44), FFIV: 128.88 (+2.73), SLXP: 102.32 (+5.33), MPWR: 45.46 (+0.59), TMH: 54.48 (+0.57), ATHM: 44.58 (+1.59)
Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 107.92 (-0.24), ANET: 77.69 (+0.72), AKRX: 38.21 (+0.53), ATHM: 44.58 (+1.59)
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.03 (-0.16), HD: 98.24 (-0.76), AKRX: 38.21 (+0.53), ILMN: 180.50 (-4.50)
SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.21 (+0.53)
Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 79.15 (+2.68), SWIR: 38.31 (-0.65), AAP: 144.81 (-1.19), AKRX: 38.21 (+0.53), BABA: 115.10 (+0.26)
Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST
AKRX: 38.21 (+0.53)
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 38.21 (+0.53)
Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 79.15 (+2.68), SWIR: 38.31 (-0.65), AKRX: 38.21 (+0.53), FRGI: 56.98 (+0.55), BABA: 115.10 (+0.26)
Akorn drops after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 12:20PM CST
AKRX: 38.21 (+0.53)
Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 38.21 (+0.53)
SmarTrend Watching for Potential Pullback in Shares of Akorn After 1.41% Gain
Comtex SmarTrend(R) - 41 mins ago
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.90 to a high of $38.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $37.85 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 38.21 (+0.53)
Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 56 mins ago
Synageva BioPharma Corp. (GEVA) announced the presentation of new data from a phase III study on sebelipase alfa for LAL deficiency.
GEVA: 75.26 (-1.84), AKRX: 38.21 (+0.53), ADHD: 3.66 (+0.06), CELG: 104.05 (-3.38)
Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 88.11 (+1.15), KBIO: 2.10 (+0.04), AKRX: 38.21 (+0.53), MYL: 54.05 (-0.68)
Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Fri Nov 14, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $37.68 on volume of 3.0 million shares, above average daily volume of 1.7 million. Akorn (NASDAQ:AKRX) has potential upside of 9.0% based on a current price of $37.68 and analysts' consensus price target of $41.08. Akorn shares should encounter resistance at the 50-day moving average (MA) of $38.00 and support at its 200-day MA of $30.77.
AKRX: 38.21 (+0.53)
Stocks Rally Back After Midday Sell-Off
at Investor's Business Daily - Thu Nov 13, 12:17PM CST
Stocks were trying to recover after a midday sell-off lopped off most of the morning gains. The Nasdaq rose 0.3%, the S&P 500 was flat and the Dow Jones industrial average was up 0.2%. Volume was running at a higher pace than at the same time...
DDS: 111.79 (-0.97), AKRX: 38.21 (+0.53), WMT: 82.96 (+0.02), THRM: 40.43 (+0.30)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 85.71 (+0.76), AKRX: 38.21 (+0.53), WPC: 66.05 (-0.60), FLWS: 8.98 (-0.03), MMSI: 14.96 (-0.08)
Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 47.84 (+0.10), AKRX: 38.21 (+0.53), AEO: 13.50 (-0.08), M: 62.05 (+0.48), FANG: 67.79 (+3.03)
Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.21 (+0.53)
Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 38.21 (+0.53)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), AFSI: 52.48 (+0.32), EXPE: 87.93 (+1.44), FFIV: 128.88 (+2.73), SLXP: 102.32 (+5.33), MPWR: 45.46 (+0.59), TMH: 54.48 (+0.57), ATHM: 44.58 (+1.59)
Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 107.92 (-0.24), ANET: 77.69 (+0.72), AKRX: 38.21 (+0.53), ATHM: 44.58 (+1.59)
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.03 (-0.16), HD: 98.24 (-0.76), AKRX: 38.21 (+0.53), ILMN: 180.50 (-4.50)
SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 38.21 (+0.53)
Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 79.15 (+2.68), SWIR: 38.31 (-0.65), AAP: 144.81 (-1.19), AKRX: 38.21 (+0.53), BABA: 115.10 (+0.26)
Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST
AKRX: 38.21 (+0.53)
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 38.21 (+0.53)
Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 79.15 (+2.68), SWIR: 38.31 (-0.65), AKRX: 38.21 (+0.53), FRGI: 56.98 (+0.55), BABA: 115.10 (+0.26)
Akorn drops after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 12:20PM CST
AKRX: 38.21 (+0.53)
Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 38.21 (+0.53)
